Gyre Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $116.5M
Liabilities Breakdown FY2023
Total Liabilities: $38.1M
Asset Breakdown
Total Assets: $116.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $33.5M | 28.8% |
| Accounts Receivable | $15.2M | 13.0% |
| Inventory | $4.3M | 3.7% |
| Property, Plant & Equipment | $23.3M | 20.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $205.0K | 0.2% |
| Other Assets | $40.1M | 34.4% |
Liabilities Breakdown
Total Liabilities: $38.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $355.0K | 0.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $37.7M | 99.1% |